# Lamotrigine

## Lamictal 50mg

| TAH Drug Code      | [OLAMC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAMC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Monotherapy in adult and children >12 year or as add-on therapy in adult and children > 2 year for the treatment of epilepsy (partial seizures and generalised seizures)， including tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. Prevention of depressive episodes in patients with bipolar disorder.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Adult & childn > 12yrs for mono therapy: Initially 25 mg once a day for 2 weeks， and 50 mg once a day for next 2 weeks， then increasing up to 50-100 mg every 1-2 weeks to achieve the desired effect. Maitenance: 100-500 mg/day in 1-2 divided doses. With valproate or without other antiepileptic drugs: the initial dose of Lamictal is 25 mg every other day for 2 weeks; then 25 mg daily for the next 2 weeks. Then increase 25-50 mg at most every 1-2 weeks to achieve an appropriate response. Maintenance: 100-200 mg/day QD or BID. With other Antiepileptic drugs or other drugs that induce lamotrigine aldose: Initially 50 mg QD for 2weeks， and 100 mg BID for the next 2 weeks. then increasing to 100 mg every 1-2 weeks to achieve the desired effect. Maintenance: 200-700 mg/day in 1-2 divided doses. With other drugs that do not significantly inhibit or induce lamotrigine aldose: Initially 25 mg QD for 2weeks， and 50 mg BID for the next 2 weeks. then increasing to 50-100 mg every 1-2 weeks to achieve the desired effect. Maintenance: 100-200 mg/day in 1-2 divided doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Common: Rash (7-14%)， Abdominal pain (immediate-release， 5-10%)， Diarrhea (5-11%)， Indigestion (immediate-release， 2-7%)， Nausea (immediate-release， 7-25%; extended-release， 7%)， Vomiting (immediate-release， 5-20%; extended-release， 6%)， Xerostomia (immediate-release， 6%; extended-release， 2%)， Backache (immediate-release， 8%)， Asthenia (2-8%)， Ataxia (immediate-release， 2-11%)， Coordination problem (3-7%)， Dizziness (immediate-release， 7-54%; extended release， 14%)， Headache (immediate-release， 29%)， Insomnia (immediate-release， 5-10%)， Somnolence (immediate-release， 9-17%; extended-release， 5%)， Tremor (4-10%)， Blurred vision (immediate-release， 11-25% (adult) and 4% (pediatric); extended-release， 3%)， Diplopia (immediate-release， 24-49% (adult) and 5% (pediatric); extended-release， 5%)， Dysmenorrhea (immediate-release， 5-7%)， Pain in throat (immediate-release， 10-14%; extended-release， 3%)， Rhinitis (immediate-release， 7-14%)， Fever (immediate-release， 6%). Serious: Abnormal cardiac conduction， Cardiac dysrhythmia， Erythema multiforme (<0.1%)， Rash， Serious (0.08-0.8%)， Stevens-Johnson syndrome， Toxic epidermal necrolysis， Anemia (immediate release， <0.1%)， Disseminated intravascular coagulation， Eosinophil count above reference range (immediate release， <0.1%)， Leukopenia (immediate release， 0.1-1%)， Thrombocytopenia (immediate release， <0.1%)， Liver failure， Drug reaction with eosinophilia and systemic symptoms， Hemophagocytic lymphohistiocytosis， Aseptic meningitis， Angioedema (<0.1%)， Neuroleptic malignant syndrome. |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/lamotrigine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

